Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
dabrafenib
×
Clear all
Filters
3
NCT02130466
2022-08-01
MK-3475-022
Merck Sharp & Dohme LLC
Phase 1/2
Completed
184 enrolled
62 charts